Prostate Cancer Screening: Shared Decision-Making for Screening and Treatment

Russ Blackwelder; Alexander Chessman

doi:10.1016/j.pop.2018.10.012

Prostate Cancer Screening: Shared Decision-Making for Screening and Treatment

Prim Care. 2019 Mar;46(1):149-155. doi: 10.1016/j.pop.2018.10.012. Epub 2018 Dec 24.

Authors

Russ Blackwelder¹, Alexander Chessman²

Affiliations

¹ Department of Family Medicine, MUSC, 5 Charleston Center, Suite 263, MSC #192, Charleston, SC 29425-0192, USA; The Village at Summerville, 201 West 9th North Street, Summerville, SC 29483, USA. Electronic address: blackwr@musc.edu.
² Department of Family Medicine, MUSC, 5 Charleston Center, Suite 263, MSC #192, Charleston, SC 29425-0192, USA.

PMID: 30704655
DOI: 10.1016/j.pop.2018.10.012

Abstract

Prostate cancer screening has generated immense interest and controversy in recent years. This article evaluates issues in current prostate cancer pathologic patterns, epidemiology, and screening.

Keywords: Cancer prevention; Men’s health; Prostate cancer; Screening.

Publication types

Review

MeSH terms

5-alpha Reductase Inhibitors / therapeutic use
Aged
Decision Making
Early Detection of Cancer*
Humans
Male
Middle Aged
Neoplasm Grading
Practice Guidelines as Topic
Prostate-Specific Antigen / blood
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / epidemiology
Prostatic Neoplasms / prevention & control
Risk Factors
United States / epidemiology

Substances

5-alpha Reductase Inhibitors
Prostate-Specific Antigen